Janux Therapeutics (JANX) Net Margin (2021 - 2026)
Janux Therapeutics (JANX) reported Net Margin of 652.59% for Q1 2026, down 168.41% on a QoQ basis from 243.13% in Q3 2025.
Janux Therapeutics (JANX) has 6 years of Net Margin data on file, last reported at 652.59% in Q1 2026.
- Quarterly Net Margin changed N/A year-over-year to 652.59% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 833.6% (down 89.0% YoY) and the FY2025 annual result came in at 1136.25%, down 48463.0% from the prior year.
- Net Margin slipped to 652.59% in Q1 2026 per JANX's latest filing, from 243.13% in the prior quarter.
- Across five years, Net Margin topped out at 66.98% in Q2 2024 and bottomed at 6391.57% in Q3 2024.
- The 5-year median for Net Margin is 714.08% (2022), against an average of 1155.62%.
- The widest annual swing landed in 2024, when Net Margin slumped 593198 bps; it then jumped 614844 bps in 2025.
- Tracing JANX's Net Margin over 5 years: stood at 564.67% in 2022, then increased by 15 bps to 477.77% in 2023, then tumbled by 1238 bps to 6391.57% in 2024, then soared by 96 bps to 243.13% in 2025, then slumped by 168 bps to 652.59% in 2026.
- Per Business Quant, the three latest JANX Net Margin figures stand at 652.59% (Q1 2026), 243.13% (Q3 2025), and 6391.57% (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.82% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 34.53% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 20.17% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 17.65% |
| 10 | Janux Therapeutics | 914.29 Mn | 914.29 Mn | - | -652.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -652.59% |
| Sep 30, 2025 | -243.13% |
| Sep 30, 2024 | -6,391.57% |
| Jun 30, 2024 | -66.98% |
| Mar 31, 2024 | -1,178.91% |
| Dec 31, 2023 | -477.77% |
| Sep 30, 2023 | -459.59% |
| Jun 30, 2023 | -1,656.39% |
| Mar 31, 2023 | -852.49% |
| Dec 31, 2022 | -564.67% |
| Sep 30, 2022 | -920.90% |
| Jun 30, 2022 | -714.08% |
| Mar 31, 2022 | -843.93% |
| Dec 31, 2021 | -830.20% |
| Sep 30, 2021 | -928.90% |
| Jun 30, 2021 | -1,287.55% |
| Mar 31, 2021 | -601.05% |